SCHEMBL3305072

SCHEMBL3305072

O=c1[nH]cnc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PNP P00491 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3305081 1.00 PNP (0.80) PNP
SCHEMBL2509842 0.81 PNP (0.54) PNP
SCHEMBL9347305 0.80 PNP (0.53) PNP
SCHEMBL3302997 0.80 PNP (0.81) PNP
SCHEMBL3302990 0.80 PNP (0.81) PNP
SCHEMBL3300632 0.79 PNP (0.52) PNP
SCHEMBL3300575 0.79 PNP (0.52) PNP
SCHEMBL3300636 0.79 PNP (0.52) PNP
Formycin B SCHEMBL29420243 0.79 PNP (0.52) PNP
SCHEMBL2104845 0.79 PNP (0.52) PNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 590 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121378732-B Dihexyl fluorene-long-chain alkyl aniline polymer and preparation method thereof 链行走新材料科技(广州)有限公司 2026-05-12 CN claimed
US-12568982-B2 Systems for retaining potency in an infused beverage VERTOSA INC. (US) 2026-03-10 US claimed
CN-121569807-A Sex pheromone and attractant for teak camelback moth and application thereof 中国林业科学研究院森林生态环境与自然保护研究所(国家林业和草原局世界自然遗产保护研究中心) 2026-02-27 CN claimed
EP-4689080-A1 PACLITAXEL (TAXOL) BIOSYNTHESIS PATHWAY Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2026-02-11 EP claimed
US-20260008784-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL USE FOR THE TREATMENT OR PREVENTION OF VASCULAR DISEASES VASTHERA CO LTD (KR) 2026-01-08 US claimed
EP-4572884-A1 SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP General Electric Technology GmbH (CH) 2025-06-25 EP claimed
CN-114094016-B Organic photoelectric synaptic device and its sound recognition method 中国科学院大学 2025-06-03 CN claimed
CN-120064477-A Pretreatment method for detecting pyrrole alkaloid protein adducts and kit 苏州帕诺米克生物科技有限公司 2025-05-30 CN claimed
CN-119767934-A Electron transport modification layer for perovskite solar cell, preparation method of electron transport modification layer and perovskite solar cell 华能青海发电有限公司 2025-04-04 CN claimed
EP-4063367-B1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME LG CHEMICAL LTD (KR) 2025-04-02 EP claimed
CN-114671898-A Luminescence-enhanced aqueous phase detection Bi3+Preparation method of luminescent crystal material 江南大学 2022-06-28 CN claimed
US-20220183972-A1 NANOEMULSION HYDROPHOBIC SUBSTANCES VERTOSA INC. 2022-06-16 US claimed
CN-110615758-B Preparation method of 9-di (4-pyridine) ethylene-fluorene with aggregation-induced emission effect 江南大学 2022-06-10 CN claimed
US-20220177666-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF ORCA HOLDINGS, LLC 2022-06-09 US claimed
WO-2022103474-A1 QUINONE-CONTAINING POLY(ARYLENE), METHODS FOR THE MANUFACTURE THEREOF, AND USE FOR ELECTROCHEMICAL GAS SEPARATION VERDOX, INC. (US) 2022-05-19 WO claimed
WO-2022066936-A1 SYSTEMS FOR RETAINING POTENCY IN AN INFUSED BEVERAGE VERTOSA INC. (US) 2022-03-31 WO claimed
US-20220087289-A1 SYSTEMS FOR RETAINING POTENCY IN AN INFUSED BEVERAGE VERTOSA INC. 2022-03-24 US claimed
CN-114094016-A Organic photoelectric synapse device and sound identification method thereof 中国科学院大学 2022-02-25 CN claimed
US-11254108-B2 Laminate structure for biocompatible barrier packaging RENOLIT SE (DE) 2022-02-22 US claimed
US-20100093991-A1 METHODS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES BIO CRYST PHARMACEUTICALS , INC. (US) 2010-04-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093991-A1 METHODS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES DPYD, TYMP, UNG PNP 8/4885
US-20220177666-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF CNR2, CNR1, CDIPT PNP 3816/4885
US-12568982-B2 Systems for retaining potency in an infused beverage TTPA, SLC6A6, PROC PNP 2533/4885
US-20260008784-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL USE FOR THE TREATMENT OR PREVENTION OF VASCULAR DISEASES PRDX1, PRDX2, PRDX6 PNP 2815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.